Medhab, LLC

Form 483 issued February 11, 2021 · Arlington, Texas

Inspection
Feb 8 – Feb 11, 2021
Investigator
Gilbert Valdez
Observations
6
Pages
2
FEI number
3013729860

In short: On February 11, 2021, FDA issued a Form 483 with 6 observations to Medhab, LLC in Arlington, Texas (FEI 3013729860) after an inspection that ran Feb 8 – Feb 11, 2021. The investigator was Gilbert Valdez. Most observations concern management controls and cAPA.

At a glance

Management controls and capa account for 4 of 6 observations.

Management controls3
CAPA1
Records & documents1
Other1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Management with executive responsibility has not reviewed the suitability and effectiveness of the quality system at…

  2. 02

    Quality audits were not performed at defined intervals and at sufficient frequency to determine whether the…

  3. 03

    Procedures for corrective and preventive action have…

  4. 04

    Personnel training is not…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Medhab, LLC?

FDA listed 6 observations on this Form 483, mostly about management controls, cAPA and records & documents. The opening words of each observation are shown on this page.

Who inspected Medhab, LLC?

Gilbert Valdez is named on this Form 483, for the inspection of Feb 8 – Feb 11, 2021. Each investigator has a profile showing what they cite most.

When was Medhab, LLC inspected by FDA?

The inspection ran Feb 8 – Feb 11, 2021, and the Form 483 is dated February 11, 2021.

How do I get the full Form 483 for Medhab, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free